Trial Profile
A phase IIa study of SCO-101 in patients with patients with chemotherapy resistant metastatic breast cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2018
Price :
$35
*
At a glance
- Drugs Endovion (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 Oct 2018 According to a Saniona media release, Scandion Oncology will finance this trial.
- 22 Dec 2017 New trial record